VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 200 filers reported holding VAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,561,750 | +12.2% | 266,021 | +9.9% | 0.10% | +1.0% |
Q2 2023 | $12,089,374 | +253.6% | 242,078 | +165.4% | 0.10% | +215.2% |
Q1 2023 | $3,418,700 | -54.6% | 91,214 | -41.9% | 0.03% | -47.6% |
Q4 2022 | $7,534,048 | +1267.3% | 157,123 | +583.8% | 0.06% | +1160.0% |
Q3 2022 | $551,000 | – | 22,979 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 4,168,718 | $90,711,000 | 29.04% |
Medicxi Ventures Management (Jersey) Ltd | 3,774,956 | $82,142,000 | 17.06% |
Pivotal bioVenture Partners Investment Advisor LLC | 832,166 | $18,108,000 | 9.12% |
GREAT POINT PARTNERS LLC | 985,153 | $21,437,000 | 5.14% |
Kynam Capital Management, LP | 723,781 | $15,749,000 | 4.02% |
Ghost Tree Capital, LLC | 325,000 | $7,072,000 | 3.68% |
Frazier Life Sciences Management, L.P. | 1,787,405 | $38,894,000 | 3.67% |
RA Capital Management | 4,581,203 | $99,687,000 | 2.66% |
Opaleye Management Inc. | 190,000 | $4,134,000 | 1.86% |
Soleus Capital Management, L.P. | 370,650 | $8,065,000 | 1.26% |